Chlorphentermine acts as a highly selective [[serotonin releasing agent]] (SRA).<ref name="pmid11071707">{{cite journal |vauthors=Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, etal | title=Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. | journal=Synapse | year= 2001 | volume= 39 | issue= 1 | pages= 32–41 | pmid=11071707 | doi=10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3 }}</ref> It is not a [[psychostimulant]] and has little or no [[abuse potential]], but is classed as a [[Controlled Substances Act#Schedule III controlled substances|Schedule III]] drug in the USA due mainly to its similarity to other appetite suppressants such as [[diethylpropion]] which have been more widely abused. It is no longer used due mainly to safety concerns, as it has a serotonergic effects profile similar to other withdrawn appetite suppressants such as [[fenfluramine]] and [[aminorex]] which were found to cause [[pulmonary hypertension]] and [[cardiac fibrosis]] following prolonged use.<ref>{{cite journal | last1 = Rothman | first1 = RB | last2 = Ayestas | first2 = MA | last3 = Dersch | first3 = CM | last4 = Baumann | first4 = MH | date = Aug 1999 | title = Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension | url = | journal = Circulation | volume = 100 | issue = 8| pages = 869–75 | doi=10.1161/01.cir.100.8.869}}</ref>
